Miwa Konishi

Title: Miwa Konishi: Innovator in Ligase Mutants

Introduction

Miwa Konishi is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of ligase mutants. Her work has implications for various applications in genetic engineering and molecular biology.

Latest Patents

Miwa Konishi holds a patent for a ligase mutant that exhibits remarkable properties. The patent details ligase mutants that include: (1) a ligase mutant comprising an amino acid sequence showing 95% or more identity to the amino acid sequence of SEQ ID NO: 1, and having a nucleic acid-linking activity; (2) a ligase mutant comprising an amino acid sequence showing 90% or more identity to the amino acid sequence of SEQ ID NO: 2, and having a nucleic acid-linking activity; or (3) a ligase mutant comprising an amino acid sequence showing 97% or more identity to the amino acid sequence of SEQ ID NO: 3, and having a nucleic acid-linking activity. This innovation is significant in enhancing nucleic acid-linking activities.

Career Highlights

Miwa Konishi is currently employed at Ajinomoto Co., Ltd., where she continues to advance her research in biotechnology. Her dedication to innovation has led to the development of her patented ligase mutants, showcasing her expertise in the field.

Collaborations

Miwa collaborates with talented colleagues, including Shohei Kajimoto and Yusuke Hagiwara. Their teamwork fosters a creative environment that enhances the research and development of new biotechnological solutions.

Conclusion

Miwa Konishi is a trailblazer in the field of ligase mutants, with her innovative patent contributing to advancements in biotechnology. Her work at Ajinomoto Co., Ltd. and collaborations with esteemed colleagues further solidify her impact in the industry.